173 related articles for article (PubMed ID: 38280141)
21. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
[TBL] [Abstract][Full Text] [Related]
22. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
[TBL] [Abstract][Full Text] [Related]
23. Probability of malignancy as determined by ThyroSeq v3 genomic classifier varies according to the subtype of atypia.
Gajzer DC; Tjendra Y; Kerr DA; Algashaamy K; Zuo Y; Menendez SG; Jorda M; Garcia-Buitrago M; Gomez-Fernandez C; Velez Torres JM
Cancer Cytopathol; 2022 Nov; 130(11):881-890. PubMed ID: 35775861
[TBL] [Abstract][Full Text] [Related]
24. Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'.
Olson MT; Clark DP; Erozan YS; Ali SZ
Acta Cytol; 2011; 55(6):518-25. PubMed ID: 22156460
[TBL] [Abstract][Full Text] [Related]
25. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
26. Molecular Testing Has Limited Utility in the Surgical Evaluation of Bethesda III Thyroid Nodules.
Scola WH; Linhares SM; Handelsman RS; Picado O; Khan ZF; Farrá JC; Lew JI
J Surg Res; 2021 Dec; 268():209-213. PubMed ID: 34358733
[TBL] [Abstract][Full Text] [Related]
27. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY
Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612
[TBL] [Abstract][Full Text] [Related]
28. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
Özkara SK; Bayrak BY; Turan G
Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
[TBL] [Abstract][Full Text] [Related]
29. Differences in Clinical Features Between Subcategories of "Atypia/Follicular Lesion of Undetermined Significance".
Kim SD; Han SH; Jeong WJ; Kim H; Ahn SH
Endocr Pathol; 2017 Sep; 28(3):247-252. PubMed ID: 28488195
[TBL] [Abstract][Full Text] [Related]
30. The evolution of "atypia" in thyroid fine-needle aspiration specimens.
Kim TH; Krane JF
Diagn Cytopathol; 2022 Apr; 50(4):146-153. PubMed ID: 34432388
[TBL] [Abstract][Full Text] [Related]
31. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
[TBL] [Abstract][Full Text] [Related]
32. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
33. Is Subdivision of Atypia of Undetermined Significance AUS/Follicular Lesion of Undetermined Significance Cases According to Detailed Nuclear Features Vital for Assessing the Risk of Malignancy?
Kaymaz E; Gun BD; Tasdoven I; Kokturk F
J Cytol; 2020; 37(4):204-209. PubMed ID: 33776262
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the risk of malignancy in The Bethesda System for the Reporting of Thyroid Cytopathology.
Elliott Range D; Jiang XS
Diagn Cytopathol; 2020 Jun; 48(6):531-537. PubMed ID: 32167682
[TBL] [Abstract][Full Text] [Related]
35. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
36. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
Kopczyński J; Suligowska A; Niemyska K; Palyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
Endokrynol Pol; 2019; 70(3):232-236. PubMed ID: 30845342
[TBL] [Abstract][Full Text] [Related]
37. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
Onder S; Firat P; Ates D
Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
[TBL] [Abstract][Full Text] [Related]
38. The 2023 Bethesda System for Reporting Thyroid Cytopathology.
Ali SZ; Baloch ZW; Cochand-Priollet B; Schmitt FC; Vielh P; VanderLaan PA
Thyroid; 2023 Sep; 33(9):1039-1044. PubMed ID: 37427847
[TBL] [Abstract][Full Text] [Related]
39. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
[TBL] [Abstract][Full Text] [Related]
40. A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.
Johnson DN; Cavallo AB; Uraizee I; Tanager K; Lastra RR; Antic T; Cipriani NA
Am J Clin Pathol; 2019 Jan; 151(1):86-94. PubMed ID: 30212867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
